AB 1001 (Haney, D-San Francisco)
Oppose
In Senate Health Committee
AB 1001 would require general acute care hospitals to adopt behavioral health emergency service policies related to minimum staffing requirements, response times, and data management and reporting. This bill would establish the Behavioral Health Emergency Response and Training Fund to support staffing increases in public and non-profit general acute care hospitals.
AB 1316 (Irwin, D-Thousand Oaks)
Sponsor
Passed the Assembly on consent on Jan. 25. Pending referral to a Senate policy committee.
AB 1316 would require that Medi-Cal managed care plans pay hospital emergency departments for serving Medi-Cal beneficiaries experiencing a mental health crisis. It would also ensure people who need access to a mental health inpatient bed are transferred promptly to the care they need.
AB 2154 (Berman, D-Palo Alto)
Neutral
Passed the Assembly Appropriations Committee on April 17. Pending an Assembly floor vote on the consent calendar.
AB 2154 would require hospitals to provide a copy of the state-published Patients’ Rights Handbook to certain family members with the consent of individuals on involuntary psychiatric holds.
AB 2700 (Gabriel, D-Encino)
Support
Passed the Assembly Health Committee on April 9. April 22 hearing in the Assembly Emergency Management Committee.
AB 2700 would promote expanded use of behavioral health facilities, rather than emergency departments (EDs), for individuals with behavioral health needs. It would require the Emergency Medical Services Authority to publish descriptions of all local agencies that are serving as, or could serve as, alternatives to hospital EDs, including psychiatric health facilities, psychiatric hospitals, sobering centers, and crisis stabilization units. The bill would also require each local emergency medical services agency to develop protocols for transporting individuals to alternate destinations.
SB 1012 (Wiener, D-San Francisco)
Follow
Passed the Senate Business, Professions and Economic Development Committee on April 15. April 23 hearing in the Senate Public Safety Committee.
SB 1012 would enact the “Regulated Psychedelic Facilitators Act” and the “Regulated Psychedelic-Assisted Therapy Act” to establish a state-regulated program that provides adults safe access to psychedelic-assisted behavioral health therapy.
SB 1017 (Eggman, D-Stockton)
Neutral
Placed on the Senate Appropriations Committee suspense file on April 15
SB 1017 would require the Department of Public Health, Department of Health Care Services, and Department of Social Services to develop a solution to collect, aggregate, and display information about beds, including acute psychiatric beds, in 13 types of behavioral health treatment facilities. This bill would take effect Jan. 1, 2026.
SB 1184 (Eggman, D-Stockton)
Follow
Passed the Senate Health Committee on March 20. April 30 hearing in the Senate Judiciary Committee.
SB 1184 would authorize administration of antipsychotic medication to a person who is involuntarily detained for evaluation and treatment for the total duration of their treatment, rather than only the first 14 days.
SB 1238 (Eggman, D-Stockton)
Support
Passed the Senate Judiciary Committee on April 16. To be heard in the Senate Appropriations Committee.
SB 1238 would expand the definition of a “designated facility” in the Lanterman-Petris-Short Act to include facilities that both (1) have appropriate services, personnel, and security to safely treat individuals being held involuntarily and (2) are licensed or certified as a skilled-nursing facility, mental health rehabilitation center, or a facility capable of providing medically monitored or managed intensive inpatient treatment for substance use disorders (SUDs). In addition, this bill would require the Department of Health Care Services (DHCS) to authorize licensed psychiatric health facilities and licensed mental health rehabilitation centers to admit individuals diagnosed only with a SUD. This bill would require DHCS to ensure that designated facilities are reimbursed for evaluation and treatment of stand-alone SUDs at rates equivalent to those provided for evaluation and treatment of mental health disorders.